Velaglucerase alfa, an enzyme replacement therapy in development for the treatment of Type 1 Gaucher disease, has been granted priority review by the United States Food and Drug Administration, maker of the drug Shire plc announced.

Ranbaxy Science Foundation (RSF), a non-profit organization set-up by Ranbaxy Laboratories Limited (RLL), has honoured Indian researchers in pharma and medicine for their outstanding contributions in its 21st Annual Research Awards for the year 2008

Tezampanel, a non opium based pain killer by Raptor Pharmaceutical Corporation, has been found effective in dealing with acute migraine and other neuropathic pain. 

Laninamivir, an inhaled drug to treat H1N1 swine flu, is also found effective against H5N1 avian influenza

Clotrimazole, current treatment against oral candidiasis is administered five times a day